SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-002910
Filing Date
2019-02-07
Accepted
2019-02-07 19:09:38
Documents
1
Period of Report
2019-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5786
  Complete submission text file 0000899243-19-002910.txt   7774
Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Reporting) CIK: 0001700449 (see all company filings)

State of Incorp.: X0
Type: 3 | Act: 34 | File No.: 001-38800 | Film No.: 19576874

Mailing Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J6EQ 44(0)20 7290 1050
Arix Bioscience Holdings Ltd (Reporting) CIK: 0001756884 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38800 | Film No.: 19576873